Table 2

Mean ratings and standard deviations for HADS and WHQ subscalesa including the level of significance as found by MANCOVA analysis (age as covariate).

SectionPre-menopause n = 42Peri-menopause n = 25Post-menopause n = 38HRT n = 36Pill n = 31Number of itemsSignificance (MANCOVA)
HADS — anxiety (SD)6.48 (3.72)8.20 (3.54)7.03 (4.51)6.97 (3.23)8.34 (4.56)70.20
HADS — depression (SD)4.21 (3.46)4.12 (3.33)3.76 (3.00)5.14 (3.70)5.10 (4.43)70.64
WHQ — somatic (SD)0.37 (0.26)0.52 (0.27)0.51 (0.29)0.50 (0.26)0.48 (0.27)70.39
WHQ — memory (SD)0.33 (0.33)0.53 (0.41)0.42 (0.40)0.47 (0.35)0.46 (0.35)30.25
WHQ — sexual (SD)0.23 (0.25)0.41 (0.35)0.40 (0.36)0.44 (0.40)0.21 (0.27)30.82
WHQ — sleep (SD)0.38 (0.34)0.52 (0.36)0.50 (0.36)0.49 (0.37)0.48 (0.34)30.67
WHQ — attractiveness (SD)0.57 (0.38)0.64 (0.40)0.54 (0.36)0.56 (0.37)0.60 (0.37)20.60
WHQ — vasomotor (SD)0.17 (0.33)0.42 (0.40)0.57 (0.46)0.42 (0.44)0.26 (0.36)20.41
WHQ — menstrual (SD)0.46 (0.29)0.58 (0.31)0.28 (0.25)0.39 (0.29)0.48 (0.32)20.01b
Difficulty coping with any of the WHQ symptoms (%)25.634.833.357.134.68.57c,d
  • aAlthough WHQ also measures anxiety and depression, the two subscales were not included as they were already addressed by HADS.

  • bP<0.01.

  • cχ2 test.

  • dNon-significant.

  • HADS = hospital anxiety and depression scale; WHQ = women's health questionnaire; HRT = hormone replacement therapy; MANCOVA = multivariate analysis of covariance; SD = standard deviation.